Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — In patients with ACS and multivessel CAD who underwent PCI, immediate complete revascularization ...
Two new parallel studies show that the novel antiplatelet drug atopaxar, an oral reversible inhibitor of the PAR-1 receptor, improves signs of ischemia without significantly increasing major bleeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results